Jpmorgan Chase & Co »

Axsome Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 190k 79.59
2023-09-30 $12M 173k 69.89
2023-06-30 $12M 173k 71.86
2023-03-31 $8.2M 133k 61.57
2022-12-31 $13M 168k 77.13
2022-06-30 $6.7M 176k 38.31
2022-03-31 $7.3M 176k 41.39
2021-12-31 $6.6M 175k 37.78
2021-03-31 $1.3M 24k 56.64
2020-12-31 $1.9M 24k 81.48
2020-09-30 $727k 10k 69.77
2020-06-30 $728k 9.5k 76.92
2020-03-31 $426k 8.7k 48.78
2019-12-31 $837k 8.1k 103.41
2019-09-30 $921k 46k 20.24
2019-06-30 $170k 6.7k 25.41
2018-09-30 $140k 41k 3.44
2018-06-30 $261k 82k 3.20
2018-03-31 $442k 180k 2.45
2017-12-31 $8.2M 1.5M 5.60
2017-06-30 $8.0M 1.4M 5.54
2017-03-31 $6.2M 1.6M 3.90
2016-12-31 $11M 1.6M 6.75
2016-09-30 $13M 1.6M 7.88
2016-06-30 $12M 1.6M 7.54
2016-03-31 $14M 1.6M 8.60
2015-12-31 $14M 1.6M 9.13